Table 2– Summary of deaths in the primary dataset

	Subjects	Asthma-related deaths		Cardiac-related deaths		Other deaths		All-cause deaths
		n (%)	Rate per TTY	n (%)	Rate per TTY	n (%)	Rate per TTY	n (%)	Rate per TTY
Formoterol-randomised patients	67 380	8 (0.012)	0.24	15 (0.022)	0.45	27 (0.040)	0.80	50 (0.074)	1.5
Salmeterol-randomised patients	4170	0	0	1 (0.024)	0.42	2 (0.048)	0.83	3 (0.072)	1.3
CBP-randomised patients	4394	0	0	3 (0.068)	1.43	0	0	3 (0.068)	1.4
Non-LABA-randomised patients	18 740	2 (0.011)	0.21	9 (0.048)	0.95	4 (0.021)	0.42	15 (0.080)	1.6
Total (all trials)	94 683	10 (0.011)	0.21	28 (0.030)	0.59	33 (0.033)	0.69	71 (0.075)	1.5

Data are presented as n, unless otherwise stated. TTY: 1000 treatment-years; CBP: current best practice; LABA: long-acting β-agonist.